Schema therapy for adults with autism and personality disorder
- Conditions
- schema therapy, adults, autism spectrum disorder, personality disorder, cognitive-behavioral, experientialschematherapie, volwassenen, autismespectrumstoornis, persoonlijkheidsstoornis, cognitief gedragstherapeutisch, experientieel
- Registration Number
- NL-OMON28080
- Lead Sponsor
- Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion criteria are a primary diagnosis of DSM-IV and/or DSM-5 autism spectrum disorder and personality disorder, age 18-65 years, with IQ at least normal intelligent (IQ > 80), at least a completed primary school and secondary education, having a reasonable degree of insight into their own personality and recognition of their (psychological) functioning, and a willingness to participate in the study for 2 years confirmed by a signed informed consent.
Exclusion criteria are schizophrenia or other psychotic disorder, antisocial PD, eating disorder, psychiatric disorders secondary to medical conditions, mental retardation (IQ < 80), addiction (that needs clinical detox) and presence of current suicidal ideation. Participants are not allowed to follow another concurrent psychological treatment at the same time. Pharmacotherapy can be used as a co-intervention during the treatment when already started before the study intervention. This is no reason for exclusion from the study. When participants have to start with pharmacotherapy or another form of (support) therapy during the study intervention, for example in case of acute crisis, this will not lead to exclusion from the study, only when this therapy and the results will be documented precisely.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Idiosyncratic belief strength: three to five idiosyncratic beliefs are formulated in collaboration with each participant, that are central to the participant’s problems. Participants will rate the degree in which they believe in each statement on 100 mm visual analogue scales (VAS; Freyd, 1923) every week during treatment and monthly at follow-up. The average score constitutes the primary outcome. The VAS is a simple and frequently used scale measure and can be used for the assessment of variations in intensity of core beliefs. When responding to a VAS item, patients specify their level of agreement to a core belief by indicating a position along a continuous line between two end-points from 0 to 100. The core beliefs are formulated during the screening procedure before the baseline phase. All participants rate on the VAS core beliefs weekly during baseline, exploration phase, cognitive-behavioral intervention phase, experiential phase, and monthly during follow-up phase.
- Secondary Outcome Measures
Name Time Method